A detailed history of Grandfield & Dodd, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 70,192 shares of PFE stock, worth $1.85 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
70,192
Previous 70,261 0.1%
Holding current value
$1.85 Million
Previous $1.97 Million 3.36%
% of portfolio
0.13%
Previous 0.13%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$27.7 - $31.39 $1,911 - $2,165
-69 Reduced 0.1%
70,192 $2.03 Million
Q2 2024

Aug 09, 2024

SELL
$25.26 - $29.6 $135,292 - $158,537
-5,356 Reduced 7.08%
70,261 $1.97 Million
Q1 2024

May 03, 2024

BUY
$25.89 - $29.73 $7,792 - $8,948
301 Added 0.4%
75,617 $2.1 Million
Q4 2023

Jan 31, 2024

SELL
$26.13 - $33.94 $352,180 - $457,443
-13,478 Reduced 15.18%
75,316 $2.17 Million
Q3 2023

Oct 25, 2023

BUY
$32.09 - $37.51 $441,430 - $515,987
13,756 Added 18.33%
88,794 $2.95 Million
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $168,535 - $194,992
-4,666 Reduced 5.85%
75,038 $2.75 Million
Q1 2023

Apr 28, 2023

BUY
$39.39 - $51.28 $3,939 - $5,128
100 Added 0.13%
79,704 $3.25 Million
Q4 2022

Jan 20, 2023

SELL
$41.75 - $54.5 $129,007 - $168,405
-3,090 Reduced 3.74%
79,604 $0
Q3 2022

Nov 03, 2022

BUY
$43.76 - $53.42 $218,493 - $266,726
4,993 Added 6.43%
82,694 $3.62 Million
Q2 2022

Aug 01, 2022

SELL
$46.53 - $55.17 $22,567 - $26,757
-485 Reduced 0.62%
77,701 $4.07 Million
Q1 2022

Apr 19, 2022

SELL
$45.75 - $56.69 $222,711 - $275,966
-4,868 Reduced 5.86%
78,186 $4.05 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $83,673 - $124,031
-2,025 Reduced 2.38%
83,054 $4.9 Million
Q3 2021

Oct 28, 2021

BUY
$39.25 - $50.42 $551,972 - $709,056
14,063 Added 19.8%
85,079 $3.66 Million
Q2 2021

Jul 28, 2021

BUY
$35.91 - $40.68 $20,791 - $23,553
579 Added 0.82%
71,016 $2.78 Million
Q1 2021

Apr 22, 2021

BUY
$33.49 - $37.77 $12,156 - $13,710
363 Added 0.52%
70,437 $2.55 Million
Q4 2020

Jan 29, 2021

BUY
$33.47 - $42.56 $20,015 - $25,450
598 Added 0.86%
70,074 $2.58 Million
Q3 2020

Nov 03, 2020

SELL
$31.75 - $37.25 $177,800 - $208,600
-5,600 Reduced 7.46%
69,476 $2.55 Million
Q2 2020

Jul 24, 2020

BUY
$30.12 - $36.54 $21,626 - $26,235
718 Added 0.97%
75,076 $2.45 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $203,860 - $291,272
-7,542 Reduced 9.21%
74,358 $2.43 Million
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $18,632 - $21,145
566 Added 0.7%
81,900 $3.21 Million
Q3 2019

Oct 30, 2019

BUY
$32.49 - $42.13 $17,869 - $23,171
550 Added 0.68%
81,334 $2.92 Million
Q2 2019

Jul 29, 2019

SELL
$36.98 - $41.52 $5,177 - $5,812
-140 Reduced 0.17%
80,784 $3.5 Million
Q1 2019

Apr 26, 2019

BUY
$37.5 - $41.2 $5,250 - $5,768
140 Added 0.17%
80,924 $3.44 Million
Q3 2018

Nov 02, 2018

SELL
$34.47 - $41.81 $1,344 - $1,630
-39 Reduced 0.05%
80,784 $3.56 Million
Q2 2018

Jul 27, 2018

BUY
$32.98 - $35.16 $4,419 - $4,711
134 Added 0.17%
80,823 $2.93 Million
Q1 2018

May 04, 2018

SELL
$31.91 - $37.02 $21,922 - $25,432
-687 Reduced 0.84%
80,689 $2.86 Million
Q4 2017

Feb 06, 2018

SELL
$33.26 - $35.29 $16,630 - $17,645
-500 Reduced 0.61%
81,376 $2.95 Million
Q3 2017

Nov 03, 2017

BUY
$31.0 - $34.15 $2.54 Million - $2.8 Million
81,876
81,876 $2.92 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Grandfield & Dodd, LLC Portfolio

Follow Grandfield & Dodd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.